Spots Global Cancer Trial Database for ibi310+ibi308
Every month we try and update this database with for ibi310+ibi308 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery | NCT04277663 | Acral Melanoma ... | IBI310+IBI308 IBI308 High-dose recom... | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. | |
The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery | NCT04277663 | Acral Melanoma ... | IBI310+IBI308 IBI308 High-dose recom... | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. |